BioTek

Agilent Brings Great Science to Life at Analytica 2024

Retrieved on: 
Thursday, April 4, 2024
Technology, Chemicals, Plastics, Health, Manufacturing, Batteries, Alternative Energy, Energy, Machinery, Research, Software, Health Technology, Hardware, Science, Semiconductor, Online, Immersion, Automation, Sustainable energy, Advanced Materials, Biotechnology, PFAS, Bioreactor, Environment, Biophysical environment, ICP-OES, MAST, Tissue, Food, ADS, Molecular biology, Laboratory, ICP-MS, Merck Group, Workflow, Agilent Technologies, Water, Chemical substance, BioTek, Fine chemical

Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows.
  • Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.
  • Agilent technical experts will be available to share insights into these latest innovations and intuitive workflows.
  • Join us as we bring Great Science to Life!

BioTek reMEDys Promotes Awareness and Education for Bleeding Disorders Awareness Month

Retrieved on: 
Wednesday, March 20, 2024
Research, Infectious Diseases, Public Policy, Government, Healthcare Reform, Biotechnology, Health, Pharmaceutical, General Health, Science, Diagnosis, Coagulopathy, Haemophilia, Caregiver, Education, Patient, Von Willebrand disease, Pharmacist, Blood, Physician, BioTek

In recognition of March being Bleeding Disorders Awareness Month , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use and treatments for patients with bleeding disorders and conditions.

Key Points: 
  • In recognition of March being Bleeding Disorders Awareness Month , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use and treatments for patients with bleeding disorders and conditions.
  • “Bleeding Disorders Awareness Month is an opportunity and a reminder to advocate for education as a priority throughout the healthcare continuum as we work towards recognizing the challenging journey patients often have on the way to a correct diagnosis and treatment."
  • Each March, the community calls attention to inheritable blood and bleeding disorders during Bleeding Disorders Awareness Month.
  • To learn more about hemophilia, von Willebrand disease, rare factor disorders and other bleeding disorders, visit hemophilia.org .

BioTek reMEDys Calls for Heightened Awareness of Safe Medication Use Around Rare Disease Day

Retrieved on: 
Thursday, February 29, 2024
Medical Supplies, Practice Management, Education, Other Consumer, Other Health, Health, Seniors, Pharmaceutical, Family, Consumer, Other Education, Physician, Disease, Pain, BioTek, Caregiver, Rare Disease Day, Approximation error, Patient, Pharmacist, Disorder, Pharmaceutical industry

In recognition of today being Rare Disease Day , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions.

Key Points: 
  • In recognition of today being Rare Disease Day , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions.
  • Rare Disease Day raises awareness for the 300 million people living with rare disease around the world and their families and caregivers.
  • To learn more about Rare Disease Day and rare conditions in general, visit rarediseaseday.org .
  • BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.

Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products

Retrieved on: 
Thursday, February 8, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Media, Communications, ADCC, Tumor microenvironment, Agilent Technologies, CPE, RTCA, Drug discovery, Exhibition, Advantage Business Media, Conference, BioTek

Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year.
  • These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development.
  • The Agilent xCELLigence RTCA HT-BioTek BioSpa 8 – Screening Model was voted Best New Drug Discovery & Development Product of 2023.
  • The Drug Discovery & Development Webinar of the Year was co-produced between Agilent and Dr. Agapitos Patakas, Chief Scientific Officer, Antibody Analytics.

BioTek reMEDys Honors the Work of Infusion Nurses on National IV Nurse Day

Retrieved on: 
Thursday, January 25, 2024
Supply Chain Management, General Health, Pharmaceutical, Training, Infectious Diseases, Hospitals, Education, Retail, Biotechnology, Nursing, Medical Supplies, Health, Physician, Patient, Pharmacy, BioTek, BSN

“National IV Nurse Day is a time to recognize the powerful impact these professionals – who we proudly work alongside on a daily basis – have on the patient population, and on the healthcare system as a whole.

Key Points: 
  • “National IV Nurse Day is a time to recognize the powerful impact these professionals – who we proudly work alongside on a daily basis – have on the patient population, and on the healthcare system as a whole.
  • “While nurses get the opportunity to work directly with the patients, we appreciate the support from the many people in the pharmacy who help to facilitate every aspect of each patient’s care.”
    Founded by the Infusion Nurse Society , an international nonprofit organization representing infusion nurses and other clinicians engaged in the specialty practice of infusion therapy, National IV Nurse Day is celebrated each year on January 25th.
  • To learn more about National IV Nurse Day, visit ins1.org/about-us/iv-nurse-day .
  • BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.

Agilent Makes Strategic Updates to Organizational Structure

Retrieved on: 
Wednesday, December 20, 2023
Stem Cells, Biotechnology, Technology, Professional Services, Health, General Health, Health Technology, Other Science, Data Analytics, Software, Science, Seahorse Bioscience, Collection, Form, Bank statement, Genomics, Growth, BioTek, Organization, DGG

“We believe having the cell analysis team as part of DGG is a natural fit given the markets they serve and the clear linkages to our genomics and diagnostics customers,” said Mike McMullen, Agilent president and CEO.

Key Points: 
  • “We believe having the cell analysis team as part of DGG is a natural fit given the markets they serve and the clear linkages to our genomics and diagnostics customers,” said Mike McMullen, Agilent president and CEO.
  • “This is an exciting opportunity to bring our unique collection of cell and molecular-based solutions together in ways that better align with how our customers are working.
  • Agilent will report under this new structure beginning with the company’s first quarter fiscal 2024 results and will recast historical segment information to conform to the new reporting structure in financial statements and accompanying notes beginning with the Form 10-Q filing.
  • To assist with the comparability of information, in January 2024, Agilent will provide a recast of the three prior years by quarter in accordance with the new reporting segments in a Form 8-K.

Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology

Retrieved on: 
Monday, December 4, 2023
Technology, Medical Devices, Medical Supplies, Genetics, Health Technology, Software, Biotechnology, Health, General Health, Hamamatsu, SCMOS, NYSE, Tissue, Immersion, Agilent Technologies, Marketing, C10, DSD, Atmosphere, Water, BioTek, CMOS, Microscope

Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader .

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader .
  • In light microscopy, water immersion technology automatically and consistently places a layer of water between the objective lens and the sample.
  • Spinning disk confocal technology improves microscopic images by blocking out-of-focus light from reaching the image sensor.
  • Additionally, integrating it with the Agilent BioTek BioSpa 8 automated incubator enables efficient multi-plate live-cell analysis.

BioTek reMEDys Urges Patients to Be Aware of Open Enrollment Deadlines

Retrieved on: 
Tuesday, November 21, 2023
Communications, Health Insurance, Other Science, Parenting, Public Policy, Government, Other Professional Services, Other Education, Insurance, Human Resources, Education, Other Consumer, Professional Services, Health, Women, Seniors, Managed Care, Men, Family, Science, Consumer, Other Communications, Other Health, Holiday, Remedial education, Marketplace, Patient, Open enrollment, COVID-19, EST, Medicare, BioTek, Physician, Health insurance, Nursing, Medicaid

With health care coverage Open Enrollment periods being well underway, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is sending out a national reminder to patients and families to be aware of their coverage status and all Open Enrollment deadlines.

Key Points: 
  • With health care coverage Open Enrollment periods being well underway, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is sending out a national reminder to patients and families to be aware of their coverage status and all Open Enrollment deadlines.
  • The Marketplace Open Enrollment Period on HealthCare.gov generally runs from November 1 to January 15.
  • BioTek reMEDys is urging its clinical and patient constituents and the population at large to check their coverage status and review the Open Enrollment periods relevant to them.
  • “During the holidays it can be easy to overlook Open Enrollment Periods,” said BioTek reMEDys’ CEO and founder Chaitanya Gadde.

BioTek reMEDys Shines a Spotlight on Pharmacists for National Pharmacy Week

Retrieved on: 
Tuesday, October 31, 2023
Research, Infectious Diseases, Biotechnology, Managed Care, Training, General Health, Pharmaceutical, Health, Science, Education, Physician, Pharmacy, Neal's Yard Remedies, Rare, BioTek, Pharmacist, Patient, Pharmaceutical industry, Nursing, Health care

“Pharmacy Strong” was the theme of this year’s National Pharmacy Week, designed to recognize the dedication and resilience of the pharmacy workforce in these unprecedented times.

Key Points: 
  • “Pharmacy Strong” was the theme of this year’s National Pharmacy Week, designed to recognize the dedication and resilience of the pharmacy workforce in these unprecedented times.
  • “Pharmacy Week is a time to recognize the powerful impact pharmacists make on patients.
  • “For us, of course, every week is Pharmacy Week, but we embrace the concept of shining a national spotlight on these essential professionals.
  • Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost.

BioTek reMEDys Celebrates the Pharmacy Professions for American Pharmacists Month

Retrieved on: 
Tuesday, October 17, 2023
Biotechnology, General Health, Health, Pharmaceutical, Managed Care, BioTek, Pharmacist, Cognitive remediation therapy, American Pharmacists Association, Patient, Education, Pharmacy technician, Rare, Pharmacy, Physician, Pharmaceutical industry, Nursing

Annually celebrated during the month of October, American Pharmacists Month has been designated by the American Pharmacists Association as a time to recognize pharmacists’ contributions to health care and all they do for their communities.

Key Points: 
  • Annually celebrated during the month of October, American Pharmacists Month has been designated by the American Pharmacists Association as a time to recognize pharmacists’ contributions to health care and all they do for their communities.
  • “American Pharmacists Month is a time to recognize the contributions and impact pharmacists, specialty pharmacists and pharmacy technicians make on patient wellbeing and on the healthcare system as a whole,” said BioTek reMEDys’ CEO and founder Chaitanya Gadde.
  • BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.
  • Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost.